Official Name | ER− breast cancer cell lines (n = 19) | ER+ breast cancer cell lines (n = 11) | FC | p-value |
---|---|---|---|---|
12 miRNAs up-regulated in ER+ compared to ER− breast tumors | ||||
miR-190b | 1.0 (0.18-3.14) | 42.9 (1.73-631) | 42.99 | <0.0001 |
miR-26a1 | 1.0 (0.36-3.22) | 3.14 (0.36-7.83) | 3.14 | 0.0477 |
miR-342-5p | 1.0 (0.26-2.72) | 8.24 (1.72-17.4) | 8.24 | <0.0001 |
miR-101-1 | 1.0 (0.50-2.54) | 2.04 (0.61-6.64) | 2.04 | 0.0111 |
let-7b | 1.0 (0.34-4.92) | 1.02 (0.01-5.24) | 1.02 | ns |
miR-30e | 1.0 (0.56-3.45) | 1.50 (0.68-2.50) | 1.50 | ns |
miR-30c2 | 1.0 (0.43-2.89) | 0.92 (0.36-3.94) | −1.09 | ns |
miR-143 | 1.0 (0.37-36.3) | 1.22 (0.37-3.84) | 1.22 | ns |
miR-26b | 1.0 (0.41-4.89) | 3.54 (0.98-7.81) | 3.54 | 0.0006 |
miR-376c | 1.0 (0.11-22.8) | 0.92 (0.00-22.1) | −1.09 | ns |
miR-193b | 1.0 (0.26-3.90) | 3.45 (0.29-12.0) | 3.45 | 0.0052 |
let-7a | 1.0 (0.50-2.01) | 0.87 (0.10-3.61) | −1.15 | ns |
8 miRNAs down-regulated in ER+ compared to ER− breast tumors | ||||
miR-18a | 1.0 (0.15-2.39) | 0.50 (0.24-25.1) | −2.00 | 0.0642 |
miR-654-3p | 1.0 (0.13-9.85) | 0.46 (0.24-1.93) | −2.17 | ns |
miR-18b | 1.0 (0.17-2.45) | 0.64 (0.16-27.5) | −1.56 | ns |
miR-155 | 1.0 (0.00-72.2) | 0.03 (0.00-0.84) | −33.3 | 0.0609 |
miR-1244 | 1.0 (0.32-1.90) | 0.91 (0.43-2.20) | −1.10 | ns |
miR-203 | 1.0 (0.01-10.0) | 5.62 (0.03-13.3) | 5.62 | 0.0226 |
miR-92a1 | 1.0 (0.41-2.46) | 0.62 (0.35-4.29) | −1.61 | 0.0707 |
miR-146a | 1.0 (0.03-91.6) | 0.11 (0.03-0.25) | −9.09 | 0.0583 |